Clinical Trials

SynerFuse has announced the first implantation in the company’s proof-of-concept study, which will evaluate the safety and tolerability of simultaneously implanting spinal fusion hardware and...

Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that it has concluded its...

The Company plans to execute its second glucose clinical study in the first quarter of 2022  Movano Inc., a health technology company designing devices that...

The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions. Japanese medical device maker Jolly Good and the Pain Center...

Enrollment was completed in less than 12 months despite COVID-related challenges, demonstrating strong interest in the therapy ONWARD Medical N.V. (Euronext: ONWD), the medical technology...

 AtaCor Medical, Inc. announced today that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study. Named the PASS-PULL EV-ICD Study,...

Study to Bolster Clinical Evidence of Performance of Patented TAEUS®Ultrasound Device in NAFLD Patients as Early Product Commercialization in Europe Continues ENDRA Life Sciences Inc. (ENDRA)...

Baxter (NYSE:BAX) announced today that data shows the potential for machine learning supporting decision-making with infusion pump programming. Deerfield, Illinois-based Baxter presented the data from a...

Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable...